VolitionRx Ltd
VNRX
9 hedge funds and large institutions have $4.25M invested in VolitionRx Ltd in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
26% more capital invested
Capital invested by funds: $3.38M → $4.25M (+$870K)
0.02% more ownership
Funds ownership: 0.24% → 0.26% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$176K |
| 2 |
Millennium Management
New York
|
+$103K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$57.7K |
| 4 |
Morgan Stanley
New York
|
+$55.7K |
| 5 |
Bank of New York Mellon
New York
|
+$39.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$47K |
| 2 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$45K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$154 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCA
1
Southpoint Capital Advisors
New York
| $3.58M | – | – | – |
|
|
2
Goldman Sachs
New York
| $206K | +$176K | +2,294 | New |
|
|
3
Millennium Management
New York
| $120K | +$103K | +1,343 | New |
|
|
4
Morgan Stanley
New York
| $116K | +$55.7K | +725 | +126% |
|
|
GBA
5
Garrison Bradford & Associates
New York
| $69K | – | – | – |
|
|
VKH
6
Virtu KCG Holdings
New York
| $67K | +$57.7K | +751 | New |
|
|
7
Bank of New York Mellon
New York
| $46K | +$39.5K | +514 | New |
|
8
UBS Group
Zurich,
Switzerland
| $38K | +$15.8K | +206 | +93% |
|
|
CS
9
Credit Suisse
Zurich,
Switzerland
| – | -$47K | -598 | Closed |
|
|
CA
10
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| – | -$45K | -575 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$154 | -2 | -67% |
|
VNRX Hedge Fund Activity: Q3 2015 in Review
9 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2015, worth a combined $4.25M — up 26% from $3.38M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VNRX positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $176K. The largest seller was Credit Suisse, exiting entirely with an estimated $47K sold.
- 9 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2015, up from 7 in Q2 2015.
- Funds reported $4.25M of VolitionRx Ltd stock for Q3 2015, up 26% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q3 2015 and 2 closed out, a net change of +2 holders.
- The largest VolitionRx Ltd buyer in Q3 2015 was Goldman Sachs, an estimated $176K added.
- The largest VolitionRx Ltd seller in Q3 2015 was Credit Suisse, an estimated $47K sold.
Based on aggregated 13F filings for Q3 2015.